TREM2 and hepatocellular carcinoma: TREM2+ LAMs were also detected in hepatocellular carcinoma and exhibited an immunosuppressive function by recruiting suppressive Treg cells via the CCL20/CXCL9/CXCL10/CXCL12–CXCR3 axes, which may compromise the antitumour response [35].